BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CardioMEMS CFO, Daniel H. Bauer, Wins the Delaney Consulting 2011 Excellence in Finance and Accounting Award


12/1/2011 10:10:16 AM

ATLANTA, Nov. 30, 2011 /PRNewswire/ -- CardioMEMS, Inc., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced that Chief Financial Officer, Daniel H. Bauer, has won Delaney Consulting, LLC's 2011 Excellence in Financing and Accounting Award in the fast-growth category. The Delaney awards acknowledge accounting and finance professionals from the Metro Atlanta area who exemplify ethics and excellence in their profession and demonstrate exceptional skill, teamwork, and the advancement and application of technical accounting and financial knowledge.

The award ceremony was held at the City Club of Buckhead on November 16, 2011. Five awards were presented, representing emerging growth, fast growth (under $500 million) and large (over $500 million) businesses. A diversity award and a CFOradio Listener's Choice award were also presented. A panel of professionals representing the finance, accounting, and education fields judged the awards.

Mr. Bauer began his career at Price Waterhouse and previously served as the Chief Financial Officer for Industriaplex, Granite City Food and Brewery, and Church's Chicken, the largest division of AFC Enterprises. He is currently a board member for the Association for Corporate Growth, a member of the advisory board of Emerge Scholarships, and an alumnus of Leadership Atlanta.

More information on the Delaney Consulting, LLC Excellence in Financing and Accounting Awards can be found at http://www.delaneyawards.com.

About Delaney Consulting, LLC
Delaney Consulting, LLC is a financial services and executive search firm that provides financial expertise to help companies achieve their financial goals. Clients engage Delaney CFOs and Controllers for their specialized financial experience and skill, whether needed on an interim, part-time or per-project basis. Clients also use Delaney's retained placement services to fit the unique needs of companies during any stage of their business lifecycle whether the company is growing, optimizing stability or undergoing challenges.

About CardioMEMS, Inc.
CardioMEMS is a medical device company that has developed and is commercializing proprietary wireless sensing and communication technology for the human body. The company's technology platform is designed to improve the management of severe chronic cardiovascular diseases such as aneurysms, heart failure, and hypertension. CardioMEMS miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data, which are critical to the management of patients. The sensors are designed to be permanently implanted into the heart and blood vessels due to their small size, durability and lack of wires and batteries. Using radiofrequency (RF) energy, the sensors transmit real-time data to external electronic readers, which then communicate this information to the patient's physician. CardioMEMS developed this technology based on the belief that frequent, on-demand, real-time monitoring of vital information enables proactive patient management, which holds the promise of reducing hospitalizations, improving a patient's quality of life and delivering more efficient and cost effective health care. More information about CardioMEMS is located at www.cardiomems.com.

Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company's products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements.

CardioMEMS and the CardioMEMS logo are registered trademarks of CardioMEMS, Inc.

SOURCE CardioMEMS, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES